Patent ID: 11931381
Assignee: YAMAGUCHI UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 17:
18. The composition according to claim 17, wherein the nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen, the nucleic acid encoding IL-7, and the nucleic acid encoding CCL19 in the expression vector (a); or the nucleic acid encoding IL-7 and the nucleic acid encoding CCL19 in the expression vector (b-2); or the nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen, and the nucleic acid encoding IL-7 in the expression vector (c-1); or the nucleic acid encoding the cell surface molecule specifically recognizing a cancer antigen, and the nucleic acid encoding CCL19 in the expression vector (d-2) are linked via a sequence encoding a self-cleaving peptide.